<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="132787">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01881178</url>
  </required_header>
  <id_info>
    <org_study_id>Nopalea</org_study_id>
    <nct_id>NCT01881178</nct_id>
  </id_info>
  <brief_title>The Effect of a Nutritional Supplement Product Containing Cactus Fruit Juice (Nopalea) on C-Reactive Protein, a Blood-Born Marker of Inflammation</brief_title>
  <acronym>NOPALEA</acronym>
  <official_title>Nopalea Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mark Mattie</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Bridgeport</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study has been developed to investigate the anti-inflammatory effects of a commercial
      product (Nopalea) containing Prickly Pear Cactus Fruit Juice in healthy adults. The research
      method employs a double blind, placebo controlled, and time-series (repeat measures) design
      with high-sensitivity C-Reactive Protein (HS-CRP) serving as a marker for inflammation -
      testing for levels of CRP at time points: baseline (pre-test), 8 weeks (60 days) and 12
      weeks (90 days). The final time point (i.e., 12 weeks) will serve as the post-test. It is
      expected that baseline CRP levels in healthy participants will decline.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>HS-CRP</measure>
    <time_frame>12 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Changes in HS-CRP</condition>
  <arm_group>
    <arm_group_label>Apricot</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Supplement: Apricot Juice</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nopalea</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Supplement: Nopalea</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>NOPALEA</intervention_name>
    <arm_group_label>Apricot</arm_group_label>
    <arm_group_label>Nopalea</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Live within traveling distance of the research center. Access to a telephone in their
        residence. Between 35 and 75 years of age Not currently ingesting Nopalea Not pregnant,
        planning to become pregnant, or nursing a child Not currently taking anti-inflammatory
        medications Medically stable - i.e. no recent major change in the last 3 weeks of
        prescription or non- prescription medication Not diagnosed with Type 1 Diabetes Not
        diagnosed with depression Not diagnosed with an acquired or congenital immune system
        deficiency
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mark E Mattie, MD, Ph.D.</last_name>
    <phone>203-576-4127</phone>
    <email>mmattie@bridgeport.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Trivita Wellness Center</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>06473</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark E Mattie, MD, Ph.D.</last_name>
    </contact>
    <investigator>
      <last_name>Mark E Mattie, MD, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 18, 2013</lastchanged_date>
  <firstreceived_date>June 17, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Bridgeport</investigator_affiliation>
    <investigator_full_name>Mark Mattie</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>CRP</keyword>
  <keyword>Nopalea</keyword>
  <keyword>Fruit</keyword>
  <keyword>Juice</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
